|Bid||204.00 x 800|
|Ask||204.25 x 800|
|Day's range||197.24 - 204.16|
|52-week range||193.34 - 281.16|
|Beta (5Y monthly)||1.00|
|PE ratio (TTM)||38.76|
|Forward dividend & yield||2.78 (1.36%)|
|Ex-dividend date||29 Jun 2022|
|1y target est||N/A|
Kalamazoo, Michigan, June 30, 2022 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will host a conference call on Tuesday, July 26, 2022 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended June 30, 2022 and provide an operational update. Final operating results for the quarter ended June 30, 2022 will be released at 4:05 p.m. that day. To register for this conference call, please use the following link: Stryker's Q2 2022 Earnings call. After regi
KALAMAZOO, Mich., June 28, 2022--Stryker (NYSE:SYK), one of the world’s leading medical technology companies, today launched an experiential campaign to inspire consumers to explore new treatment options for bunions and increase awareness of the benefits of bunion surgery. The interactive campaign consists of visually creative chalk designs in four major metropolitan cities – New York City, Los Angeles, Chicago and Miami – prompting passersby to learn more.
KALAMAZOO, Mich., May 31, 2022--Stryker (NYSE:SYK) today announced that its Q Guidance System received 510(k) clearance from the U.S. Food and Drug Administration.